|
|
???tair.name??? >
???browser.page.title.author???
|
"su w p"???jsp.browse.items-by-author.description???
Showing items 41-65 of 76 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-05-26T09:26:57Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Lu Y.-S;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Chih-Hsin Yang; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T07:35:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Chia-Chi Lin; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; Lu Y.-S; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:14Z |
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
|
Aarts M.J.B; Erdkamp F.L.G; Blaisse R.J.B; Flores C.L.U; Cort?s L.V; Lee Y.-G; Kim Y.J; Rha S.Y; Ferrario C; Sengeloev L; Jensen N.V; Thibault C; Laguerre B; Joly F; Flechon A; Culine S; Becht C; Niegisch G; St?ckle M; Grimm M.-O; Gakis G; Schultze-Seemann W; Kalofonos H; Mavroudis D; Papandreou C; Karavasilis V; R?v?sz J; Geczi L; Rosenbaum E; Leibowitz-Amit R; Kejzman D; Sarid D; Scagliotti G.V; Bracarda S; Massari F; Osawa T; Miyajima N; Shinohara N; Fukuta F; Ohyama C; Obara W; Yamashita S; Tomita Y; Kawai K; Fukasawa S; Oyama M; Yonese J; Nagata M; Uemura M; Nishimura K; Kawakita M; Tsunemori H; Hashine K; Inokuchi J; Yokomizo A; Nagamori S; Lee H.J; Park S.H; Alekseev B; Necchi A; G?czi L; Ou Y.-C; Coskun H.S; Su W.-P; Hegemann M; Percent I.J; Lee J.-L; Tucci M; Semenov A; Laestadius F; Peer A; Tortora G; Safina S; del Muro X.G; Rodriguez-Vida A; Cicin I; Harputluoglu H; Widau R.C; Liepa A.M; Walgren R.A; Hamid O; Zimmermann A.H; Bell-McGuinn K.M; Powles T; Wong S.-L.S; Tan T.H; Hovey E.J; Clay T.D; Ng S.S.W; Rutten A; Machiels J.-P; Dumez H; Cheng S.Y.-S; Petrylak D.P; de Wit R; Chi K.N; Drakaki A; Sternberg C.N; Nishiyama H; Castellano D; Hussain S; Fl?chon A; Bamias A; Yu E.Y; van der Heijden M.S; Matsubara N; Vaishampayan U.; Aragon-Ching J; Tagawa S; Lawler W; Lowe T; Herms B; Hainsworth J; Cultrera J; Schwarz J; Flaig T; Pan C.X; Wojcik-Tomaszewska J; Tomczak P; Sikora-Kupis B; Schenker M; Herzal A.A; Udrea A.A; Karlov P; Fomkin R; Pulido E.G; Mignorance J.I.D; Gauna D.C; Rodr?guez-Vida A; Su Y.-L; Lin C.-L; Chia-Chi Lin; Yeh S.-P; ?i?in I; Erman M; Urun Y; Golovko Y; Bondarenko I; Sinielnikov I; Crabb S; Syndikus I; Huddart R; Sundar S; Chowdhury S; Sarwar N |
| 臺大學術典藏 |
2020-05-25T07:35:03Z |
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
|
Petrylak D.P; de Wit R; Chi K.N; Drakaki A; Sternberg C.N; Nishiyama H; Castellano D; Hussain S.A; Fl?chon A; Bamias A; Yu E.Y; van der Heijden M.S; Matsubara N; Alekseev B; Necchi A; G?czi L; Ou Y.-C; Coskun H.S; Su W.-P; Bedke J; Gakis G; Percent I.J; Lee J.-L; Tucci M; Semenov A; Laestadius F; Peer A; Tortora G; Safina S; Garcia del Muro X; Rodriguez-Vida A; Cicin I; Harputluoglu H; Tagawa S.T; Vaishampayan U; Aragon-Ching J.B; Hamid O; Liepa A.M; Wijayawardana S; Russo F; Walgren R.A; Zimmermann A.H; Hozak R.R; Bell-McGuinn K.M; Powles T; Wong S.-L.S; Tan T.H; Hovey E.J; Clay T.D; Wan Ng S.S; Rutten A; Machiels J.-P; Dumez H; Cheng S.Y.-S; Ferrario C; Sengeloev L; Jensen N.V; Thibault C; Laguerre B; Joly F; Culine S; Becht C; Niegisch G; St?ckle M; Grimm M.-O; Schwentner C.A; Schultze-Seemann W; Kalofonos H; Mavroudis D; Papandreou C; Karavasilis V; R?v?sz J; Rosenbaum E; Leibowitz-Amit R; Kejzman D; Sarid D; Scagliotti G.V; Bracarda S; Massari F; Osawa T; Miyajima N; Shinohara N; Fukuta F; Ohyama C; Obara W; Yamashita S; Tomita Y; Kawai K; Fukasawa S; Oyama M; Yonese J; Nagata M; Uemura M; Nishimura K; Kawakita M; Tsunemori H; Hashine K; Inokuchi J; Yokomizo A; Nagamori S; Lee H.J; Park S.H; Rha S.Y; Kim Y.J; Lee Y.-G; Vazquez Cort?s L; Lorena Urzua Flores C; Blaisse R.J.B; Erdkamp F.L.G; Aarts M.J.B; Wojcik-Tomaszewska J; Tomczak P; Sikora-Kupis B; Schenker M; Herzal A.A; Udrea A.A; Karlov P; Fomkin R; Gajate Borau P; Grande E; Delgado Mignorance J.I; Su Y.-L; Li J.-R; Lin C.-L; Chia-Chi Lin; Yeh S.-P; Erman M; Urun Y; Golovko Y; Bondarenko I; Sinielnikov I; Crabb S.J; Syndikus I; Huddart R; Sundar S; Chowdhury S; Sarwar N; Flaig T.W; Pan C.X; Schwarz J.K; Cultrera J.L; Acs P.I; Hainsworth J.D; Herms B.T; Lawler W.E; Lowe T.E. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P;Wen C.-C;Hsiung C.A;Su I.-J;Cheng A.-L;Chang M.-C;Tsao C.-J;Kao W.-Y;Uen W.-C;Hsu C.-H;Yen-Shen Lu;Tien H.-F;Chao T.-Y;Chen L.-T;Whang-Peng J;Chen P.-J.; Su W.-P; Wen C.-C; Hsiung C.A; Su I.-J; Cheng A.-L; Chang M.-C; Tsao C.-J; Kao W.-Y; Uen W.-C; Hsu C.-H; YEN-SHEN LU; Tien H.-F; Chao T.-Y; Chen L.-T; Whang-Peng J; Chen P.-J. |
| 臺大學術典藏 |
2020-05-25T06:51:54Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C;Su W.-C;Yen C.-J;Hsu C.-H;Su W.-P;Yeh K.-H;Yen-Shen Lu;Cheng A.-L;Huang D.C.-L;Fritsch H;Voss F;Taube T;Yang J.C.-H.; Lin C.-C; Su W.-C; Yen C.-J; Hsu C.-H; Su W.-P; Yeh K.-H; YEN-SHEN LU; Cheng A.-L; Huang D.C.-L; Fritsch H; Voss F; Taube T; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Chiun Hsu;Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chiun Hsu; Yang P.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:25Z |
Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer
|
Gow C.-H.; Chiun Hsu; Chang G.-C.; Yang P.-C.; Su W.-P.; Lin C.-P.; Yang T.-Y.; Yu C.-J.; Chen K.-C.; Shih J.-Y.; Yang C.-H.; Yang C.-H.;Shih J.-Y.;Chen K.-C.;Yu C.-J.;Yang T.-Y.;Lin C.-P.;Su W.-P.;Gow C.-H.;Chiun Hsu;Chang G.-C.;Yang P.-C. |
| 臺大學術典藏 |
2020-03-26T06:54:22Z |
Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer
|
Wang C.-Y.; Chao T.-T.; Tai W.-T.; Chang F.-Y.; Su W.-P.; Chen Y.-L.; Chen P.-T.; Weng C.-Y.; ANG YUAN; Shiau C.-W.; Yu C.-J.; Chen K.-F. |
| 臺大學術典藏 |
2020-03-07T06:56:54Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Yih-Leong Chang;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Yang P.-C.; Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-06T05:26:38Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C. |
| 臺大學術典藏 |
2020-01-22T07:46:24Z |
Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks
|
MAU-SUN CHANG; Liaw H.; Myung K.; Wu W.-S.; Hung P.-C.; Hung J.-J.; Yang W.-B.; Chang M.-S.; Chen Y.-C.; Shih M.-Y.; Lin Y.-J.; Jiang Z.-D.; Chang S.-B.; Lin J.-Y.; Chia L.-C.; Hsu S.-H.; Su W.-P.;Hsu S.-H.;Chia L.-C.;Lin J.-Y.;Chang S.-B.;Jiang Z.-D.;Lin Y.-J.;Shih M.-Y.;Chen Y.-C.;Chang M.-S.;Yang W.-B.;Hung J.-J.;Hung P.-C.;Wu W.-S.;Myung K.;Liaw H.; Su W.-P. |
| 國立成功大學 |
2020 |
The HLTF–PARP1 interaction in the progression and stability of damaged replication forks caused by methyl methanesulfonate
|
Shiu, J.-L.;Wu, C.-K.;Chang, S.-B.;Sun, Y.-J.;Chen, Y.-J.;Lai, C.-C.;Chiu, W.-T.;Chang, W.-T.;Myung, K.;Su, W.-P.;Liaw, H. |
| 國立成功大學 |
2020 |
Rich p-type-doping phenomena in boron-substituted silicene systems: Boron-substituted silicene
|
Pham, H.D.;Su, W.-P.;Nguyen, T.D.H.;Tran, N.T.T.;Lin, M.-F. |
| 國立成功大學 |
2020 |
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
|
Petrylak, D.P.;de, Wit R.;Chi, K.N.;Drakaki, A.;Sternberg, C.N.;Nishiyama, H.;Castellano, D.;Hussain, S.A.;Fl�chon, A.;Bamias, A.;Yu, E.Y.;van, der Heijden M.S.;Matsubara, N.;Alekseev, B.;Necchi, A.;G�czi, L.;Ou, Y.-C.;Coskun, H.S.;Su, W.-P.;Bedke, J.;Gakis, Gakis G.;Percent, I.J.;Lee, J.-L.;Tucci, M.;Semenov, A.;Laestadius, F.;Peer, A.;Tortora, G.;Safina, Safina S.;Garcia, del Muro X.;Rodriguez-Vida, A.;Cicin, I.;Harputluoglu, Harputluoglu H.;Tagawa, S.T.;Vaishampayan, U.;Aragon-Ching, J.B.;Hamid, O.;Liepa, A.M.;Wijayawardana, S.;Russo, F.;Walgren, R.A.;Zimmermann, A.H.;Hozak, R.R.;Bell-McGuinn, K.M.;Powles, T.;Wong, S.-L.S.;Tan, Tan T.H.;Hovey, E.J.;Clay, T.D.;Wan, Ng S.S.;Rutten, A.;Machiels, J.-P.;Dumez, H.;Cheng, S.Y.-S.;Ferrario, C.;Sengeloev, L.;Jensen, N.V.;Thibault, C.;Laguerre, B.;Joly, F.;Culine, S.;Becht, C.;Niegisch, G.;St�ckle, M.;Grimm, M.-O.;Schwentner, C.A.;Schultze-Seemann, W.;Kalofonos, H.;Mavroudis, D.;Papandreou, C.;Karavasilis, V.;R�v�sz, J.;Rosenbaum, E.;Leibowitz-Amit, R.;Kejzman, D.;Sarid, D.;Scagliotti, G.V.;Bracarda, S.;Massari, F.;Osawa, T.;Miyajima, N.;Shinohara, N.;Fukuta, Fukuta F.;Ohyama, C.;Obara, W.;Yamashita, S.;Tomita, Y.;Kawai, Kawai K.;Fukasawa, S.;Oyama, M.;Yonese, J.;Nagata, M.;Uemura, M.;Nishimura, K.;Kawakita, M.;Tsunemori, H.;Hashine, K.;Inokuchi, J.;Yokomizo, A.;Nagamori, S.;Lee, H.J.;Park, S.H.;Rha, S.Y.;Kim, Y.J.;Lee, Y.-G.;Vazquez, Cort�s L.;Lorena, Urzua Flores C.;Blaisse, R.J.B.;Erdkamp, F.L.G.;Aarts, M.J.B.;Wojcik-Tomaszewska, J.;Tomczak, P.;Sikora-Kupis, B.;Schenker, M.;Herzal, A.A.;Udrea, A.A.;Karlov, P.;Fomkin, R.;Gajate, Borau P.;Grande, E.;Delgado, Mignorance J.I.;Su, Y.-L.;Li, J.-R.;Lin, C.-L.;Lin, C.-C.;Yeh, S.-P.;Erman, M.;Urun, Y.;Golovko, Y.;Bondarenko, I.;Sinielnikov, I.;Crabb, S.J.;Syndikus, I.;Huddart, R.;Sundar, Sundar S.;Chowdhury, S.;Sarwar, N.;Flaig, T.W.;Pan, C.X.;Schwarz, J.K.;Cultrera, J.L.;Acs, P.I.;Hainsworth, J.D.;Herms, B.T.;Lawler, W.E.;Lowe, T.E. |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 國立成功大學 |
2018 |
The diverse magneto-optical selection rules in bilayer black phosphorus
|
Wu, J.-Y.;Chen, S.-C.;Do, T.-N.;Su, W.-P.;Gumbs, Gumbs G.;Lin, M.-F. |
| 國立成功大學 |
2015-07 |
Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks
|
Su, W. -P.; Su, W. -C.; Wu, W. -S.; Liaw, H. |
| 國立成功大學 |
2014-05-13 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H |
| 淡江大學 |
2014-02-13 |
Compact Li-doped Gd2Ti2O7 prepared with LiO0.5 self-flux
|
Wen, L.C.; Hsieh, H.Y.; Chang, S.C.; Lin, M.Y.; Lee, Y.H.; Su, W.P.; Kao, H.-C.I.; Sheu, H.S.; Jang, L.Y.; Lee, M.C.; Lee, Y.S. |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立成功大學 |
2013-08 |
Electric modulation effect on magneto-optical spectrum of monolayer graphene
|
Ou, Y. C.; Chiu, Y. H.; Lu, J. M.; Su, W. P.; Lin, M. F. |
| 國立成功大學 |
2013-05-21 |
Precessing anisotropic Dirac cone and Landau subbands along a nodal spiral
|
Ho, C. H.; Chang, C. P.; Su, W. P.; Lin, M. F. |
| 國立成功大學 |
2011-03-08 |
Characterization of Landau subbands in graphite: A tight-binding study
|
Ho, Y. H.; Wang, J.; Chiu, Y. H.; Lin, M. F.; Su, W. P. |
Showing items 41-65 of 76 (4 Page(s) Totally)
<< < 1 2 3 4 > >>
View [10|25|50] records per page
|
